Prawo i regulacje · 27/02/2014

DEA Proposes Rescheduling of Hydrocodone Combination Products to Schedule II

The Drug Enforcement Administration (DEA) is proposing to reschedule hydrocodone combination products from Schedule III to Schedule II under the Controlled Substances Act, following a recommendation from the Assistant Secretary for Health and an evaluation of relevant data. If finalized, this action would impose stricter controls on the handling of these products.